AK106-001616
- Generic Name
- AK106-001616
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H25N3O3
- CAS Number
- 590416-75-4
- Unique Ingredient Identifier
- I2CST2BV1Q
- Background
AK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-01-28
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 240
- Registration Number
- NCT01285752
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 130
- Registration Number
- NCT00902369
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath